Equity Capital Markets

Company · CIK 1789972

Cullinan Therapeutics, Inc.

CIK1789972 (SEC EDGAR)
Industry (SIC)2836 — Biological Products, (No Diagnostic Substances)
Incorporated inDE
Business addressMA
ListedCGEM (Nasdaq)
First annual or quarterly report2021-03-30

Offerings

4 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-295363
ShelfEffective
 2026-04-282026-04-281
333-279452
ShelfEffective
 2024-05-162024-06-042
333-270384
ShelfEffective
 2023-03-092023-05-182
333-251512
IPOFinal prospectus
 2020-12-182021-01-116

Filings

12
FiledFilingRegistrationAccession
2026-04-28S-3ASRShelf registered 333-2953630001193125-26-183596
2024-06-04EFFECTDeclared effective 333-2794529999999995-24-001737
2024-05-16S-3Shelf registered 333-2794520001193125-24-140544
2023-05-18EFFECTDeclared effective 333-2703849999999995-23-001468
2023-03-09S-3Shelf registered 333-2703840001193125-23-065343
2021-01-11424B4Final prospectus 333-2515120001193125-21-005478
2021-01-07EFFECTDeclared effective 333-2515129999999995-21-000071
2021-01-06S-1/AAmendment 333-2515120001193125-21-003224
2021-01-04S-1/AAmendment 333-2515120001193125-21-000161
2020-12-28S-1/AAmendment 333-2515120001193125-20-326964
2020-12-18S-1Registration filed 333-2515120001193125-20-321670
2020-11-02DRSDraft made public 377-037340000950123-20-010687

All filings of this company · CSV